Atlas Trials

COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CF

Clinical trial NCT05054582 · COMPLETED

Trial details

NCT number
NCT05054582
Sponsor
Medical University Innsbruck
Status
COMPLETED
Study type
OBSERVATIONAL
Cystic FibrosisCovid19
Start date
2021-09-01
Primary completion
2024-09-30
Enrollment
152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.